• F2G

  • Andrea Deschambeault

Andrea Deschambeault

Senior Medical Science Liaison at F2G

Andrea Deschambeault has a wealth of work experience, beginning in 2010 when they were a Clinical Assistant Professor at the University of New England. Andrea then moved to Maine Medical Center to take on the roles of Infectious Diseases Clinical Pharmacist and Interim Co-director, Antimicrobial Stewardship Program. In 2014, they held the role of Clinical Pharmacist at CNY Infusion Services, as well as Director, Global Health Sciences | Infectious Diseases Care at The Medicines Company, providing scientific and clinical support for their Infectious Disease portfolio. In 2018, they joined Nabriva Therapeutics plc as Director Medical Affairs, Regional Director, Field Medical Affairs, and Senior Medical Science Liaison. That same year, they were also a Medical Science Director at Melinta Therapeutics. Currently, they are a Senior Medical Science Liaison at F2G.

Andrea Deschambeault obtained their Doctor of Pharmacy (PharmD) from the Massachusetts College of Pharmacy and Health Sciences between 2002 and 2008. Andrea then obtained their Maine Pharmacist license from the Maine Board of Pharmacy in October 2008. In November 2011, they were awarded their Board Certified Pharmacotherapy Specialist (BCPS) from the Board of Pharmacotherapy Specialist. Finally, they obtained their NY Pharmacist license from the New York State Board of Pharmacy in October 2013.

Location

Buffalo, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


F2G

1 followers

F2G is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections.


Industries

Employees

51-200

Links